These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1450410)

  • 61. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL.
    Shivdasani RA; Mayer EL; Orkin SH
    Nature; 1995 Feb; 373(6513):432-4. PubMed ID: 7830794
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transcriptional regulation of the stem cell leukemia gene by PU.1 and Elf-1.
    Bockamp EO; Fordham JL; Göttgens B; Murrell AM; Sanchez MJ; Green AR
    J Biol Chem; 1998 Oct; 273(44):29032-42. PubMed ID: 9786909
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice.
    Chervinsky DS; Zhao XF; Lam DH; Ellsworth M; Gross KW; Aplan PD
    Mol Cell Biol; 1999 Jul; 19(7):5025-35. PubMed ID: 10373552
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene.
    Wang J; Jani-Sait SN; Escalon EA; Carroll AJ; de Jong PJ; Kirsch IR; Aplan PD
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3497-502. PubMed ID: 10737801
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The stem cell leukaemia (SCL) gene: a critical regulator of haemopoietic and vascular development.
    Barton LM; Göttgens B; Green AR
    Int J Biochem Cell Biol; 1999 Oct; 31(10):1193-207. PubMed ID: 10582347
    [No Abstract]   [Full Text] [Related]  

  • 66. Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T-cell acute lymphoblastic leukemia and follicular lymphoma.
    Hosler GA; Bash RO; Bai X; Jain V; Scheuermann RH
    Am J Pathol; 1999 Apr; 154(4):1023-35. PubMed ID: 10233841
    [TBL] [Abstract][Full Text] [Related]  

  • 67. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.
    Huang S; Qiu Y; Stein RW; Brandt SJ
    Oncogene; 1999 Sep; 18(35):4958-67. PubMed ID: 10490830
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The bHLH TAL-1/SCL regulates endothelial cell migration and morphogenesis.
    Lazrak M; Deleuze V; Noel D; Haouzi D; Chalhoub E; Dohet C; Robbins I; Mathieu D
    J Cell Sci; 2004 Mar; 117(Pt 7):1161-71. PubMed ID: 14970264
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of SCL/Tal-1, GATA, and ets transcription factor binding sites for the regulation of flk-1 expression during murine vascular development.
    Kappel A; Schlaeger TM; Flamme I; Orkin SH; Risau W; Breier G
    Blood; 2000 Nov; 96(9):3078-85. PubMed ID: 11049987
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia.
    Shimamoto T; Ohyashiki K; Ohyashiki JH; Kawakubo K; Fujimura T; Iwama H; Nakazawa S; Toyama K
    Blood; 1995 Oct; 86(8):3173-80. PubMed ID: 7579412
    [TBL] [Abstract][Full Text] [Related]  

  • 71. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
    Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
    Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Transcription factors of the bHLH and LIM families: synergistic mediators of T cell acute leukemia?
    Baer R; Hwang LY; Bash RO
    Curr Top Microbiol Immunol; 1997; 220():55-65. PubMed ID: 9103675
    [No Abstract]   [Full Text] [Related]  

  • 73. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
    Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
    Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL).
    Lowsky R; DeCoteau JF; Reitmair AH; Ichinohasama R; Dong WF; Xu Y; Mak TW; Kadin ME; Minden MD
    Blood; 1997 Apr; 89(7):2276-82. PubMed ID: 9116269
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system.
    Visvader J; Begley CG; Adams JM
    Oncogene; 1991 Feb; 6(2):187-94. PubMed ID: 2000219
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chromatin immunoselection defines a TAL-1 target gene.
    Cohen-Kaminsky S; Maouche-Chrétien L; Vitelli L; Vinit MA; Blanchard I; Yamamoto M; Peschle C; Roméo PH
    EMBO J; 1998 Sep; 17(17):5151-60. PubMed ID: 9724651
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression of a chimeric helix-loop-helix gene, Id-SCL, in K562 human leukemic cells is associated with nuclear segmentation.
    Goldfarb AN; Wolf ML; Greenberg JM
    Am J Pathol; 1992 Nov; 141(5):1125-37. PubMed ID: 1443047
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A single split-signal FISH probe set allows detection of TAL1 translocations as well as SIL-TAL1 fusion genes in a single test.
    van der Burg M; Smit B; Brinkhof B; Barendregt BH; Verschuren MC; Dib M; Beverloo HB; van Dongen JJ; Langerak AW
    Leukemia; 2002 Apr; 16(4):755-61. PubMed ID: 11960364
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes.
    Tremblay M; Tremblay CS; Herblot S; Aplan PD; Hébert J; Perreault C; Hoang T
    Genes Dev; 2010 Jun; 24(11):1093-105. PubMed ID: 20516195
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Quantification of minimal residual disease in T-lineage acute lymphoblastic leukemia with the TAL-1 deletion using a standardized real-time PCR assay.
    Chen X; Pan Q; Stow P; Behm FG; Goorha R; Pui CH; Neale GA
    Leukemia; 2001 Jan; 15(1):166-70. PubMed ID: 11243385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.